JPWO2023028657A5 - - Google Patents
Info
- Publication number
- JPWO2023028657A5 JPWO2023028657A5 JP2024513926A JP2024513926A JPWO2023028657A5 JP WO2023028657 A5 JPWO2023028657 A5 JP WO2023028657A5 JP 2024513926 A JP2024513926 A JP 2024513926A JP 2024513926 A JP2024513926 A JP 2024513926A JP WO2023028657 A5 JPWO2023028657 A5 JP WO2023028657A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cell
- receptor
- binding domain
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021902832A AU2021902832A0 (en) | 2021-09-01 | Methods and compositions for stimulating immune activity | |
| AU2021902832 | 2021-09-01 | ||
| PCT/AU2022/051070 WO2023028657A1 (en) | 2021-09-01 | 2022-09-01 | Methods and compositions for stimulating immune activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532482A JP2024532482A (ja) | 2024-09-05 |
| JPWO2023028657A5 true JPWO2023028657A5 (https=) | 2025-08-01 |
| JP2024532482A5 JP2024532482A5 (https=) | 2025-08-01 |
Family
ID=85410590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513926A Pending JP2024532482A (ja) | 2021-09-01 | 2022-09-01 | 免疫活性を刺激するための方法および組成物 |
| JP2024513973A Pending JP2024532489A (ja) | 2021-09-01 | 2022-09-01 | 新規の機能不全ｐ２ｘ７結合剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513973A Pending JP2024532489A (ja) | 2021-09-01 | 2022-09-01 | 新規の機能不全ｐ２ｘ７結合剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240376193A1 (https=) |
| EP (2) | EP4395814A4 (https=) |
| JP (2) | JP2024532482A (https=) |
| CN (2) | CN117813109A (https=) |
| AU (2) | AU2022335932A1 (https=) |
| CA (2) | CA3223086A1 (https=) |
| MX (2) | MX2023015028A (https=) |
| WO (2) | WO2023028657A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4400516A1 (en) * | 2014-12-15 | 2024-07-17 | The Regents of the University of California | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 |
| CN119792512A (zh) * | 2020-10-14 | 2025-04-11 | 维里迪安治疗公司 | 用于治疗甲状腺眼病的组合物和方法 |
| TW202320850A (zh) | 2021-08-10 | 2023-06-01 | 美商維里迪恩醫療股份有限公司 | 用於治療甲狀腺眼病之組合物、劑量及方法 |
| JP2026507807A (ja) * | 2023-03-08 | 2026-03-06 | バイオセプター （オースト） プロプライエタリー・リミテッド | 機能不全ｐ２ｘ７受容体に結合するためのキメラ抗原受容体 |
| WO2024211413A2 (en) * | 2023-04-05 | 2024-10-10 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Trogocytosis in cancer cells and methods for treating cancer related thereto |
| WO2024220870A1 (en) * | 2023-04-19 | 2024-10-24 | The University Of Chicago | Antibody-targeted enzymatic chemoprotection |
| AU2024269870A1 (en) * | 2023-05-05 | 2025-11-20 | Board Of Regents, The University Of Texas System | Multi-receptor natural killer cells |
| AU2024306505A1 (en) * | 2023-06-30 | 2025-10-16 | Biosceptre (Aust) Pty Ltd | Molecules and methods for activating car t cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2904911T3 (es) * | 2009-08-20 | 2022-04-06 | Biosceptre Aust Pty Ltd | Anticuerpos anti-receptor P2X7 y fragmentos de los mismos |
| JP5992831B2 (ja) * | 2009-12-24 | 2016-09-14 | バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド | 非機能性オリゴマーｐ２ｘ７受容体に対する抗体 |
| US20180037650A1 (en) * | 2015-04-02 | 2018-02-08 | Biosceptre (Uk) Limited | Pain Treatment |
| EP3347474B1 (en) * | 2015-09-11 | 2020-11-04 | Biosceptre (UK) Limited | Chimeric antigen receptors and uses thereof |
| CN109862883A (zh) * | 2016-10-21 | 2019-06-07 | 生物权威（英国）有限公司 | 细胞毒性颗粒 |
| EP3797164A4 (en) * | 2018-05-21 | 2022-03-02 | Biosceptre (Aust) Pty Ltd | CHIMERIC ANTIGEN RECEPTORS WITH MODIFIED LINKER DOMAINS AND THEIR USES |
| JP7682797B2 (ja) * | 2019-03-20 | 2025-05-26 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | クローディン６二重特異性抗体 |
| KR20210148228A (ko) * | 2019-03-27 | 2021-12-07 | 내셔날 리서치 카운실 오브 캐나다 | 항-EGFRvIII 항체 및 그의 항원-결합 단편 |
| JP2024510739A (ja) * | 2021-03-11 | 2024-03-11 | バイオセプター （オースト） プロプライエタリー・リミテッド | 新規な細胞治療システム |
-
2022
- 2022-09-01 MX MX2023015028A patent/MX2023015028A/es unknown
- 2022-09-01 MX MX2023015469A patent/MX2023015469A/es unknown
- 2022-09-01 US US18/686,554 patent/US20240376193A1/en active Pending
- 2022-09-01 WO PCT/AU2022/051070 patent/WO2023028657A1/en not_active Ceased
- 2022-09-01 EP EP22862431.8A patent/EP4395814A4/en active Pending
- 2022-09-01 EP EP22862427.6A patent/EP4395813A4/en active Pending
- 2022-09-01 CA CA3223086A patent/CA3223086A1/en active Pending
- 2022-09-01 CA CA3223079A patent/CA3223079A1/en active Pending
- 2022-09-01 CN CN202280053364.9A patent/CN117813109A/zh active Pending
- 2022-09-01 JP JP2024513926A patent/JP2024532482A/ja active Pending
- 2022-09-01 US US18/688,086 patent/US20240368282A1/en active Pending
- 2022-09-01 CN CN202280059679.4A patent/CN117881421A/zh active Pending
- 2022-09-01 JP JP2024513973A patent/JP2024532489A/ja active Pending
- 2022-09-01 AU AU2022335932A patent/AU2022335932A1/en active Pending
- 2022-09-01 WO PCT/AU2022/051066 patent/WO2023028653A1/en not_active Ceased
- 2022-09-01 AU AU2022341030A patent/AU2022341030A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7551693B2 (ja) | ＮＫｐ４６結合タンパク質の可変領域 | |
| JP7550591B2 (ja) | 多重特異的ＮＫｐ４６結合タンパク質 | |
| Labrijn et al. | Bispecific antibodies: a mechanistic review of the pipeline | |
| JP6971153B2 (ja) | 多重特異的ｎｋエンゲイジャータンパク質 | |
| WO2020113164A1 (en) | Heterodimeric tetravalency and specificity antibody compositions and uses thereof | |
| JP7611931B2 (ja) | ガイダンス及びナビゲーションコントロール（ｇｎｃ）抗体様タンパク質、その製造方法及び使用方法 | |
| US20160009824A1 (en) | Tetravalent bispecific antibodies | |
| BR112021009325A2 (pt) | Anticorpo monoclonal, ou fragmento de ligação ao antígeno do mesmo; anticorpo biespecífico; método para prevenir ou tratar um câncer suscetível em um ser humano; método de ensaio de expressão de sirp¿ em células tumorais e/ou imunes; e; composição farmacêutica | |
| US20220396635A1 (en) | Trivalent binding molecules | |
| KR20230143177A (ko) | 신규한 항-cd24 항체 | |
| JP7592712B2 (ja) | ガイダンス及びナビゲーションコントロールタンパク質、その製造方法及び使用方法 | |
| US20240190987A1 (en) | Engineered EpCam Binding Antibodies | |
| TW202221015A (zh) | 單一及雙靶定配體誘導之t細胞銜接體組合物 | |
| JPWO2023028657A5 (https=) | ||
| US20250101104A1 (en) | Bispecific molecule with tunable affinity to a targeted antigen | |
| JP7854121B2 (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 | |
| CA2990518C (en) | Multispecific nk engager proteins | |
| HK40129137A (zh) | 制导和导航控制(gnc)抗体样蛋白及其制备和使用方法 | |
| JPWO2024039672A5 (https=) |